Fundamentals of HCT of Training Course

The 2023 Fundamentals of HCT Training Course is a two-day conference that will be taking place virtually on Friday, April 28 - Saturday, April 29, 2023. This course provides a broad overview and introduction of hematopoietic cell transplantation (HCT), also referred to as blood and marrow transplantation (BMT), as well as cellular immunotherapy (CI). Throughout the lectures, participants will be introduced to numerous aspects of the HCT-CI processes, which are designed to develop or enhance skills required in the management of patients undergoing these procedures. This course incorporates case-based learning to emphasize application of concepts taught through didactic lecture with a strong focus on the pharmacotherapeutic management. The target audience for this course includes new practitioners, residents, fellows, pharmacists, and nurses or those training in this discipline.


Type: Price:
ASTCT Member Rate $300
Non-Member Rate $375
Fellow/Trainee Rate $250
eBook registration add on* $150

*With this add on, attendees will reserve a copy of the newly revised 2023 Fundamentals of HCT Training Course eBook once it is completed in late spring/early summer 2023.

Attendees will have access to the virtual platform until May 28, 2023 to review recordings, but please note that to obtain ACPE and ACCME credits, you need to attend the live sessions on April 28-29 2023. No CE credits are offered for viewing the recorded/enduring content. Please review the full accreditation information at the bottom of this page for instructions on participation and requesting credit.

Cancellation Policy

Registered attendees will have access to the recordings until May 28, 2023. Therefore, ASTCT will not be refunding any registrations to the 2023 virtual Fundamentals of HCT Training Course. Registration payments are non-transferable. 

Program Agenda*

Day 1; Friday, April 28, 2023



8:00 – 8:10 AM ET

Welcome – Opening Remarks

Lauren Ice, PharmD, BCOP, BCPS; Corewell Health, Grand Rapids, MI

8:10 – 9:10 AM ET

Introduction to Transplant

Jason Ernstberger, PharmD, BCOP; University of Cincinnati Medical Center, Cincinnati, OH

9:15 – 10:00 AM ET

Hematopoietic Stem Cell Mobilization                     

Erika Wass, PharmD, BCOP; Loma Linda University Medical Center, Loma Linda CA

10:00 – 10:15 AM ET


10:15 – 11:15 AM ET

Principles of Conditioning in Hematopoietic Cell Transplantation

Taiga Nishihori, MD; Moffitt Cancer Center, Tampa, FL

11:20 – 11:50 AM ET

Sinusoidal Obstruction Syndrome

Katie Gatwood, PharmD, BCOP; Vanderbilt University, Nashville, TN

11:50 – 12:30 PM ET


12:30 – 1:00 PM ET

Thrombotic Microangiopathy in Hematopoietic Cell Transplantation

Hemalatha Rangarajan, MD; Nationwide Children's Hospital, Columbus, OH

1:05 – 2:05 PM ET

Special Populations in Hematopoietic Cell Transplantation: Pediatrics

Susie Long, PharmD; University of Minnesota, Minneapolis, MN

2:05 – 2:15 PM ET


2:15 – 3:00 PM ET

Immune Effector Cell Products and Indications

Jennifer Collins, PharmD, BCOP; University of Chicago Medicine, Chicago, IL

3:05 – 3:50 PM ET

Immune Effector Cell Toxicity Management

Craig Freyer, PharmD, BCOP; University of Pennsylvania, Philadelphia, Pennsylvania

3:50 – 4:00 PM ET


4:00 – 4:30 PM ET

Virtual Roundtable Discussion & Wrap-Up (No CE provided)

All Faculty

Day 1 concludes

(6.25 CE)


Program Agenda – Day 2: Saturday, April 29, 2023



8:00 – 8:45 AM ET

Fungal Infections in Hematopoietic Cell Transplantation

Arpita Gandhi, PharmD, BCOP; Emory Healthcare - Winship Cancer Institute, Atlanta, GA

8:50 – 9:50 AM ET

Viral Infections in Hematopoietic Cell Transplantation

LeAnne Kennedy, PharmD, BCOP: Wake Forest University, Winston-Salem, NC

9:50 – 10:05 AM ET


10:05 – 10:50 AM ET

Vaccinations in Hematopoietic Cell Transplantation and Cellular Therapy

Susan Prockop, MD; Boston Children’s Hospital, Boston, MA

10:55 – 12:10 PM ET

Acute Graft versus Host Disease

Elizabeth DiMaggio, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL

12:10 – 12:45 PM ET


12:45 – 2:00 PM ET

Chronic Graft versus Host Disease

Rebecca Gonzalez, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL

2:05 – 2:50 PM ET

Maintenance Strategies after Hematopoietic Cell Transplantation

Jason Yeh, PharmD, BCOP; University of Texas MD Anderson Cancer Center, Houston, TX

2:50 – 3:00 PM ET


3:00 – 4:00 PM ET

Long Term Complications and Survivorship in Hematopoietic Cell Transplantation

Ila Saunders, PharmD, BCOP; UC San Diego Skaggs School of Pharmacy, San Diego, CA

4:05 – 4:30 PM ET

Virtual Roundtable Discussion & Wrap-Up (No CE provided)

All Faculty

Day 2 concludes

(6.75 CE)

agenda is subject to change


Please see the course syllabus here.


There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the activity, and completing the evaluation form.

Credit Fulfillment

  • If you are requesting AMA credits or a certificate of participation, your certificate will be available for download.
  • If you are a pharmacist requesting ACPE credits, your credit request will be uploaded to CPE Monitor within 60 days after the activity.

Note: There is ONE evaluation for the entire program, not one for each individual session. A link for the CE evaluation will be provided post-conference.


Technical Requirements:

This activity is jointly provided by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT).




Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physician Credit Designation

The France Foundation designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



This knowledge-based activity qualifies for 13.0 contact hours (0.13 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (



The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and ASTCT resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ASTCT seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ASTCT are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Disclosures for members of the planning committee and faculty will be disclosed to learners prior to the conference and can also be found here.


Disclosure of Unlabeled Use:

The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational. They must also disclose limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off label use of these medications. TFF and ASTCT do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


This activity is supported by independent medical educational grants from Merck, Jazz Pharmaceuticals, and Incyte.


The France Foundation and the American Society for Transplantation and Cellular Therapy present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, The American Society for Transplantation and Cellular Therapy, and the commercial supporter(s) assume no liability for the information herein.


If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or